 ft 14 92 intern compani news novo nordisk profit surg 38  novo nordisk danish pharmaceut industri enzym group increas quarter net profit 38 cent dkr324m dollar 51m dkr234m sale 20 cent dkr2 66bn dkr2 22bn quarter year pre tax profit 33 cent higher rise dkr354m dkr470m earn share increas 18 cent dkr7 41m dkr8 74m novo nordisk warn sale profit rise fast rest year quarter result affect fact import custom deliveri shipment earlier expect sale boost currenc factor compani expect achiev 15 cent growth pre tax profit line long term earn object group capit expenditur increas strong dkr1 3bn dkr2bn aim increas product capac intern 